Executive Director in charge of International Affairs, Strategy, Development and Research
Pascal LAGARDE, 59, graduated from the Ecole Polytechnique (X 82) and the Ecole Nationale Supérieure des Techniques Avancées.
He began his career as head of program at the General Delegation for Armament of the French Ministry of Defense, in the telecommunications sector (1987-1993). At the Ministry in charge of the Industry (1994-1998) he became successively the assistant of the “electronic components” assistant director and “IT and telecommunications” assistant director. In September 1999, Pascal LAGARDE was appointed Head of the Venture and Seed Capital Department of CDC PME (Groupe Caisse des Dépôts) and, in 2001, assistant Managing Director of CDC PME, and Chairman of its subsidiary CDC PME Gestion, in charge of public mid-caps investments. In June 2003, he was appointed Managing Director of CDC PME. In September 2006, as part of the reorganization of the private equity activities of Caisse des Dépôts, Pascal LAGARDE was appointed Managing Director of CDC Entreprises, in charge of CDC general interest programs for SMEs equity financing : venture capital, expansion capital and smallcap LBOs. CDC Entreprises was a management company, managing a total of 7,8 B€ in fund of funds and direct investment funds. Its LPs included the CDC group, public and private financial institutions, and industrials firms. Following the creation of Bpifrance, Pascal LAGARDE has been appointed in July 2013 Executive Director of Bpifrance, in charge of strategy, development, international affairs and ESG. From 2016 to 2022, Pascal Lagarde served as Chairman of The Montreal Group, a global forum for development banks focused on micro, small and medium-sized enterprises. He also co-founded the European Venture Fund Investors Network (EVFIN), a platform for dialogue launched in March 2011 by major national investors in venture capital in response to the continuing funding crisis in this sector across the EU.
Pascal Lagarde is a board member of the European Investment Fund (EIF), Cita, Five capital partners, Healthcare promise and the Institutional Investors Roundtable (IIR).
He is also a member of Novethic strategic committee.